Piper Sandler Just Hiked Humana Price Target to $254: Medicare Advantage Beat Powers the Bull Case

Humana (NYSE:HUM) banal received a terms people rise to $254 from $182 from Piper Sandler, which maintained a Neutral rating. The determination follows a Q1 2026 net bushed driven by stronger Medicare Advantage show and a favorable aesculapian nonaccomplishment ratio (MLR). For prudent investors, the enactment signals that the longer-term borderline betterment thesis is backmost successful focus, adjacent arsenic Piper stays cautious connected near-term execution.

The astir $72 terms people rise ranks among the largest single-firm moves connected Humana banal this cycle, reflecting Piper's presumption that Humana has 560 ground points of Individual MA borderline enlargement disposable crossed 2027 and 2028, the cardinal bull lawsuit successful the call. The magnitude of the revision underscores Piper's condemnation successful the multi-year borderline story.

The Analyst's Case

Piper anchored its revised presumption connected Humana's Q1 aesculapian nonaccomplishment ratio bushed and Medicare Advantage trends that were accordant with to somewhat amended than plan, successful some caller and tenured membership. The steadfast flagged that Humana is intimately monitoring admissions, discharge, and transfer; pharmacy; authorization; and claims data, with April inclination appearing unchangeable arsenic of April 29.

The expert who called NVIDIA successful 2010 conscionable named his apical 10 stocks and Humana wasn't 1 of them. Get them present FREE.

The centerpiece of the upgrade is borderline opportunity. Piper's 560 ground points of Individual MA borderline enlargement estimation crossed 2027 and 2028 matters due to the fact that MLR is the ascendant nett lever for immoderate wellness insurer.

Company Snapshot

Humana is simply a managed-care insurer with brands including Humana, CenterWell, and OneHome, and a marketplace capitalization of astir $33 billion. Q1 2026 adjusted EPS came successful astatine $10.31 versus the $10.20 consensus, with gross of $39.65 billion, up 24% twelvemonth implicit twelvemonth (YoY).